NEW ANALYSIS: Drug Companies Continue To Hike Prices At Will; Congress Must Act
Patients For Affordable Drugs’ Analysis Highlights Need For Medicare Negotiation For All Drugs
Analysis: DRUG COMPANIES CONTINUE TO HIKE PRICES AT WILL
Take a look at this year's price hikes to see why Congress must act now.
July 2021 Price Hikes Methodology
P4AD analyzed the wholesale acquisition cost (WAC) data for the 170 unique National Drug Codes (NDCs) with price hikes greater than 1% or $1 that were posted between July 1 and July 6.
Luxury pricing for a necessity.
This insulin is currently priced at almost $300 per bottle. It is luxury pricing for a medication that I literally cannot live without.
Changes are terrifying because of the high price of insulin
I have to scrimp and save to afford to eat. But I know other senior citizens who are much worse off — some are even eating cat food to be able to afford their drugs.
TODAY: Patient, P4AD Founder David Mitchell Tells Senate Judiciary Subcommittee That Anticompetitive Pharma Industry Practices Stifle Innovation, Drive Up Prices
Mitchell Urges Congress To Pass Bipartisan Solutions To Address Anticompetitive Behavior And To Allow Medicare To Negotiate Lower Drug Prices
New Report Reveals Big Pharma’s Influence On Patient Advocacy Groups
Pharmaceutical Industry’s Financial Power And Influence Remain Strong And Far-Reaching As Drug Pricing Legislation Moves Forward
Drug prices have made me sicker
Drug prices have made me sicker and far less functional than I would be if I had affordable access to the proper medications.
